nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['nivolumab', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'renal,(-adrenal)', 'check,mate,9er', 'nivo']
#ascogu23 nivolumab plus cabozantinib vs sunitinib for first-line treatment of advanced renal cell carcinoma (arcc): 3-year follow-up from the phase 3 checkmate 9er trial 
Medicina Interna - Oncología Clínica - Clínica Astorga. Profesor titular @upbcolombia #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis